Real-Time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Targeted With Existing Drugs or Used as Biomarkers. [electronic resource]
Producer: 20190628Description: 2242-2253.e4 p. digitalISSN:- 1528-0012
- Adenocarcinoma, Mucinous -- diagnosis
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- administration & dosage
- Biomarkers, Tumor -- analysis
- Carcinoma, Pancreatic Ductal -- drug therapy
- Chromosome Mapping -- methods
- Cohort Studies
- Female
- Fibroblast Growth Factor-23
- Gene Expression Regulation, Neoplastic
- Genetic Variation -- drug effects
- Genomic Structural Variation
- Humans
- Male
- Middle Aged
- Molecular Targeted Therapy -- methods
- Neoplasm Invasiveness -- pathology
- Neoplasm Staging
- Pancreatic Neoplasms -- drug therapy
- Real-Time Polymerase Chain Reaction -- methods
- Retrospective Studies
- Young Adult
No physical items for this record
Publication Type: Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.